Discover 764 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 764
A Safety, Tolerability and Pharmacokinetic Study of cP12 in Adults With Up To 10% Total Body Surface Area Burns
for
Thermal Burns
Location: Washington D.C. DC
Sponsor: Neomatrix Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT06814717
Phase2, Recruiting
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
for
Renal Pelvis and Ureter Urothelial Carcinoma
Location: Washington D.C. DC, Baltimore MD, Hershey PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04628767
Phase2, Phase3, Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
for
Acute Respiratory Distress Syndrome (ARDS), ARDS,
Location: Washington D.C. DC, New Brunswick NJ, The Bronx NY,
Sponsor: PPD Development, LP
Sex: All
Age: 18+
Code: NCT06701669
Phase2, Recruiting
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging
Location: Washington D.C. DC, Glen Burnie MD, Baltimore MD,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06661720
Phase3, Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: Washington D.C. DC, Fairfax VA, Baltimore MD, Towson MD,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136650
Phase3, Recruiting
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
for
Refractory Angina
Location: Washington D.C. DC, Charlottesville VA, Norfolk VA,
Sponsor: Shockwave Medical, Inc.
Sex: All
Age: 18+
Code: NCT05102019
Recruiting
Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy
for
Pulmonary Embolism
Location: Washington D.C. DC, Newark DE, Wynnewood PA,
Sponsor: NYU Langone Health
Sex: All
Age: 18+
Code: NCT05591118
Phase3, Recruiting
RevCore for In Stent Thrombosis
for
In-stent Thrombosis
Location: Washington D.C. DC, Philadelphia PA, Norfolk VA,
Sponsor: Inari Medical
Sex: All
Age: 18+
Code: NCT06394739
Recruiting
Cognitive Behavioral Theory-assisted Virtual Reality for Chronic CANcer Pain (VR-CAN)
for
Cancer, Cancer Pain, Chronic Cancer Pain
Location: Washington D.C. DC, Durham NC
Sponsor: Medstar Health Research Institute
Sex: All
Age: 18+
Code: NCT07318519
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Location: Washington D.C. DC, Philadelphia PA, Naples FL,
Sponsor: argenx
Sex: All
Age: 18+
Code: NCT07091630
Phase3, Recruiting
Telerehabilitation In The Home After Stroke
for
Stroke
Location: Washington D.C. DC, Elkins Park PA, New York NY,
Sponsor: University of California, Los Angeles
Sex: All
Age: 18 - 70+
Code: NCT06682429
Recruiting
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)
for
Central Line Associated Blood Stream Infections (CLABSI)
Location: Washington D.C. DC, Baltimore MD, Philadelphia PA,
Sponsor: CorMedix Therapeutics
Sex: All
Age: 18+
Code: NCT06822426
Phase3, Recruiting
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Location: Washington D.C. DC, Falls Church VA, Baltimore MD,
Sponsor: Eidos Therapeutics, a BridgeBio company
Sex: All
Age: 18 - 70+
Code: NCT06563895
Phase3, Recruiting
Retrospective Long-term Safety and Efficacy Study of the Beta-Cath(TM) 3.5F System
for
Coronary In-stent Restenosis
Location: Washington DC
Sponsor: Best Vascular, Inc.
Sex: All
Age: 0+
Code: NCT00852176
Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Washington D.C. DC, Falls Church VA, Baltimore MD,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07207811
Phase3, Recruiting
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
for
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Location: Washington D.C. DC, Falls Church VA, Baltimore MD,
Sponsor: Intellia Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06128629
Phase3, Recruiting
Digital Intervention for Symptom Management in Cancer and Opioid Sparing Using Virtual Reality (DISCOVR) Study